AvKARE FDA Inspection Record

FEI 3007255004 · Inspections, Form 483s, warning letters and import refusals

AvKARE is an FDA-inspected facility (FEI 3007255004) located in Pulaski, TN, US. RegDataLab tracks 4 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Nov 2, 2022: Voluntary Action Indicated (VAI)
Inspections on record
4 (1 VAI, 3 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
41, latest Oct 9, 2026
Import refusals
2

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Nov 2, 2022Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Aug 23, 2022No Action Indicated (NAI)No citations listed
Jun 6, 2017No Action Indicated (NAI)No citations listed
Jun 9, 2014No Action Indicated (NAI)No citations listed

Recalls

Showing the 10 most recent of 41 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Oct 9, 2026Class IID-0157-2027Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK…
Failed Impurities/Degradation Specifications
Feb 13, 2026Class IID-0341-2026Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only…
Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
Dec 31, 2025Class IID-0292-2026Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton…
Out of specification for dissolution.
Sep 2, 2025Class IID-0007-2026Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and…
Failed Content Uniformity Specifications
Aug 25, 2025Class IID-0643-2025chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx… and 1 more product
Presence of a foreign substance.
Jun 26, 2025Class IIID-0528-2025Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE… and 1 more product
Failed Impurity/Degradation Specifications
May 13, 2025Class IID-0460-2025Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured…
Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200…
May 9, 2025Class IID-0461-2025Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only…
Failed Dissolution Specifications
Feb 4, 2025Class IID-0229-2025Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN…
Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9%…
Jan 21, 2025Class IID-0224-2025Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured…
Out of Specification for Dissolution

FDA record score

82 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

31 records behind this number
RecordDatePoints x age weightAdds
Class I recall D-0444-2024, this FEI as the recalling firmMar 28, 202415 x 0.69
Class II recall D-0157-2027, this FEI as the recalling firmOct 9, 20264 x 14
Class II recall D-0341-2026, this FEI as the recalling firmFeb 13, 20264 x 14
Class II recall D-0292-2026, this FEI as the recalling firmDec 31, 20254 x 14
Class II recall D-0007-2026, this FEI as the recalling firmSep 2, 20254 x 14
Class II recall D-0643-2025, this FEI as the recalling firmAug 25, 20254 x 14
Class II recall D-0460-2025, this FEI as the recalling firmMay 13, 20254 x 14
Class II recall D-0461-2025, this FEI as the recalling firmMay 9, 20254 x 14
Class II recall D-0229-2025, this FEI as the recalling firmFeb 4, 20254 x 14
Class II recall D-0224-2025, this FEI as the recalling firmJan 21, 20254 x 14
Class II recall D-0168-2025, this FEI as the recalling firmDec 4, 20244 x 14
Class II recall D-0108-2025, this FEI as the recalling firmNov 27, 20244 x 14
Class I recall D-0167-2021, this FEI as the recalling firmDec 7, 202015 x 0.253.8
Inspection classified VAINov 2, 20226 x 0.63.6
Class II recall D-0103-2025, this FEI as the recalling firmOct 18, 20244 x 0.62.4
Class II recall D-1146-2023, this FEI as the recalling firmAug 11, 20234 x 0.62.4
Class II recall D-0091-2023, this FEI as the recalling firmDec 22, 20224 x 0.62.4
Class II recall D-0070-2021, this FEI as the recalling firmOct 30, 20204 x 0.251
Class II recall D-1304-2020, this FEI as the recalling firmJun 4, 20204 x 0.251
Class II recall D-0661-2020, this FEI as the recalling firmJan 7, 20204 x 0.251
Class II recall D-0524-2020, this FEI as the recalling firmNov 14, 20194 x 0.251
Class II recall D-0164-2020, this FEI as the recalling firmOct 17, 20194 x 0.251
Class II recall D-1875-2019, this FEI as the recalling firmAug 28, 20194 x 0.251
Class II recall D-1249-2019, this FEI as the recalling firmApr 24, 20194 x 0.251
Class II recall D-1044-2019, this FEI as the recalling firmMar 5, 20194 x 0.251
Class II recall D-0285-2019, this FEI as the recalling firmNov 20, 20184 x 0.251
Class II recall D-1130-2018, this FEI as the recalling firmAug 14, 20184 x 0.251
Class II recall D-0633-2018, this FEI as the recalling firmMar 30, 20184 x 0.251
Class II recall D-0222-2018, this FEI as the recalling firmJan 3, 20184 x 0.251
Class II recall D-0055-2018, this FEI as the recalling firmOct 6, 20174 x 0.251
Class II recall D-0610-2017, this FEI as the recalling firmFeb 15, 20174 x 0.251

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing AvKARE as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check AvKARE yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
AvKARE
Location
Pulaski, TN (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.